The FDA plans to use Medco’s large claims database to understand “the real-world application of a test,” inform pharmacogenomics assessments of drug safety and efficacy, and update drug labels with genetic risk information.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.